Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Ibuprofen

Ibuprofen

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Ibuprofen:

BioPortfolio Logo
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 29th October, 2009 Cumberland Pharmaceuticals Inc.
Nashville, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have
Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 26th October, 2009 Horizon Therapeutics, Inc.
SAN DIEGO, Oct. 26 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today presented an analysis from two pivotal Phase 3 trials (REDUCE-1 and REDUCE-2)
Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims to Medicaid 19th October, 2009 U.S. Department of Justice
WASHINGTON, Oct. 19 /PRNewswire-USNewswire/ -- Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical have entered into settlement agreements for a total
Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief in Post-Operative Patients 19th October, 2009 Cumberland Pharmaceuticals Inc.
NASHVILLE, Tenn., Oct. 19 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was
Cumberland Pharmaceuticals Announces Presentation of Caldolor Data at American Academy of Pain Management Meeting 5th October, 2009 Cumberland Pharmaceuticals Inc.
-- A phase III abdominal hysterectomy pain study entitled "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen for the Management of

Companies working in the area of Ibuprofen from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

SCOLR Pharma

Based in Bellevue, Washington, SCOLR Pharma is a specialty pharmaceutical company that leverages itsformulation expertise, and its proprietary and patented drug delivery technologies to develop...
www.scolr.com/        View full profile
Thumbshot

This page has been viewed 36 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Ibuprofen across BioPortfolio, or for Ibuprofen Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.